Date: 10-Aug-2019

USFDA inspection of Alathur facility completed with zero observations: Strides

New Delhi: Drug firm Strides Pharma Science on Friday said its Alathur facility in Chennai has successfully completed inspection by the US health regulator with zero observations. The companys formulation facility at Alathur in Chennai underwent a United States Food and Drug Administration (USFDA) inspection from August 5 to 9, 2019, Strides Pharma Science said in a filing to the BSE.